{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "99227085",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\ProgramData\\Anaconda3\\lib\\site-packages\\Bio\\Entrez\\__init__.py:734: UserWarning: \n",
      "            Email address is not specified.\n",
      "\n",
      "            To make use of NCBI's E-utilities, NCBI requires you to specify your\n",
      "            email address with each request.  As an example, if your email address\n",
      "            is A.N.Other@example.com, you can specify it as follows:\n",
      "               from Bio import Entrez\n",
      "               Entrez.email = 'A.N.Other@example.com'\n",
      "            In case of excessive usage of the E-utilities, NCBI will attempt to contact\n",
      "            a user at the email address provided before blocking access to the\n",
      "            E-utilities.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "PMID: 39156700, Title: Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer., Year: 2024\n",
      "PMID: 39156639, Title: Reversion of pathogenic <i>BRCA1</i> L1780P mutation confers resistance to PARP and ATM inhibitor in breast cancer., Year: 2024\n",
      "PMID: 39155781, Title: Single-cell transcriptomics reveals tumor landscape in ovarian carcinosarcoma., Year: 2024\n",
      "PMID: 39154703, Title: Restoration of TFPI2 by LSD1 Inhibition Suppresses Tumor Progression and Potentiates Antitumor Immunity in Breast Cancer., Year: 2024\n",
      "PMID: 39154430, Title: Can contralateral prophylactic mastectomy and oophorectomy increase survival in BRCA-related breast cancer? Results from the Italian MUTina study., Year: 2024\n",
      "PMID: 39154426, Title: Targeted gene panel sequencing of liquid and tissue biopsies reveals actionable genomic alterations in Ghanaian metastatic breast cancer cases., Year: 2024\n",
      "PMID: 39152355, Title: Advancements in targeting tumor suppressor genes (p53 and BRCA 1/2) in breast cancer therapy., Year: 2024\n",
      "PMID: 39150003, Title: Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer., Year: 2024\n",
      "PMID: 39149814, Title: A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer., Year: 2024\n",
      "PMID: 39148954, Title: Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods., Year: 2024\n",
      "PMID: 39146492, Title: Clinical and molecular features of early onset pancreatic adenocarcinoma., Year: 2024\n",
      "PMID: 39145508, Title: Quantum-Dot-Encoded Beads-Enhanced CRISPR/Cas-Based Lateral-Flow Assay for the Amplification-Free, Sensitive, and Rapid Detection of Nucleic Acids in Breast Cancer., Year: 2024\n",
      "PMID: 39145413, Title: Strategies for the prevention or reversal of PARP inhibitor resistance., Year: 2024\n",
      "PMID: 39144243, Title: Case Report of Complete Response to Olaparib in a Patient with Breast Cancer Brain Metastases., Year: 2024\n",
      "PMID: 39143110, Title: Structural basis for a Polθ helicase small-molecule inhibitor revealed by cryo-EM., Year: 2024\n",
      "PMID: 39142283, Title: Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel., Year: 2024\n",
      "PMID: 39138583, Title: Clinical characteristics and genetic analysis of a case of a patient with familial hereditary breast cancer: a case report., Year: 2024\n",
      "PMID: 39138354, Title: Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin., Year: 2024\n",
      "PMID: 39137480, Title: Addressing the knowledge gap in the genomic landscape and tailored therapeutic approaches to adolescent and young adult cancers., Year: 2024\n",
      "PMID: 39136593, Title: In Vitro and In Vivo Biological Evaluation of Novel 1,4-Naphthoquinone Derivatives as Potential Anticancer Agents., Year: 2024\n",
      "PMID: 39135999, Title: Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer., Year: 2024\n",
      "PMID: 39135527, Title: Olaparib monotherapy or in combination with abiraterone for treating mutated metastatic castration-resistant prostate cancer: alone or stronger together?, Year: 2024\n",
      "PMID: 39135053, Title: Synergistic antitumor effect of liposomal-based formulations of olaparib and topotecan in primary epithelial ovarian cancer cells., Year: 2024\n",
      "PMID: 39134950, Title: Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancer., Year: 2024\n",
      "PMID: 39133448, Title: Development of a Novel Protocol for Germline Testing in Pancreatic Cancer., Year: 2024\n",
      "PMID: 39132489, Title: Genetic associations with human longevity are enriched for oncogenic genes., Year: 2024\n",
      "PMID: 39128337, Title: Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations., Year: 2024\n",
      "PMID: 39127886, Title: Triple-Negative Pleomorphic Lobular Carcinoma in a BRCA1 Mutation Carrier: A Case of Complete Pathological Response., Year: 2024\n",
      "PMID: 39127414, Title: Prognostic prediction and immune checkpoint profiling in glioma patients through neddylation-associated features., Year: 2024\n",
      "PMID: 39126824, Title: Molecular analysis of non-small cell lung cancer using a dual-targeted DNA and RNA comprehensive genomic profiling panel., Year: 2024\n",
      "PMID: 39125994, Title: Aqueous Extracts of <i>Ocimum gratissimum</i> Sensitize Hepatocellular Carcinoma Cells to Cisplatin through BRCA1 Inhibition., Year: 2024\n",
      "PMID: 39122831, Title: Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors., Year: 2024\n",
      "PMID: 39120972, Title: The deubiquitinase BAP1 and E3 ligase UBE3C sequentially target IRF3 to activate and resolve the antiviral innate immune response., Year: 2024\n",
      "PMID: 39120648, Title: R-loops and impaired autophagy trigger cGAS-dependent inflammation via micronuclei formation in Senataxin-deficient cells., Year: 2024\n",
      "PMID: 39119242, Title: Synthesis of nimbolide and its analogues and their application as poly(ADP-ribose) polymerase-1 trapping inducers., Year: 2024\n",
      "PMID: 39117746, Title: Involvement of the splicing factor SART1 in the BRCA1-dependent homologous recombination repair of DNA double-strand breaks., Year: 2024\n",
      "PMID: 39117659, Title: Histone-methyltransferase KMT2D deficiency impairs the Fanconi anemia/BRCA pathway upon glycolytic inhibition in squamous cell carcinoma., Year: 2024\n",
      "PMID: 39117504, Title: Immediate Psychological Implications of Risk-Reducing Mastectomies in Women With Increased Risk of Breast Cancer: A Comparative Study., Year: 2024\n",
      "PMID: 39116683, Title: Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study., Year: 2024\n",
      "PMID: 39116356, Title: Genomic Profiling of Small Intestine Cancers From a Real-World Data Set Identifies Subgroups With Actionable Alterations., Year: 2024\n",
      "PMID: 39116124, Title: R-loop functions in <i>Brca1</i>-associated mammary tumorigenesis., Year: 2024\n",
      "PMID: 39115450, Title: Exocyclic and Linker Editing of Lys63-linked Ubiquitin Chains Modulators Specifically Inhibits Non-homologous End-joining Repair., Year: 2024\n",
      "PMID: 39115414, Title: Abiraterone, Olaparib, or Abiraterone + Olaparib in First-line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway)., Year: 2024\n",
      "PMID: 39115289, Title: BRCA1/BRC-1 and SMC-5/6 regulate DNA repair pathway engagement during <i>C. elegans</i> meiosis., Year: 2024\n",
      "PMID: 39115191, Title: Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer., Year: 2024\n",
      "PMID: 39113697, Title: The Interaction of Calcium-Sensing Receptor with KIF11 Enhances Cisplatin Resistance in Lung Adenocarcinoma via BRCA1/cyclin B1 pathway., Year: 2024\n",
      "PMID: 39112709, Title: The genomic landscape of 2,023 colorectal cancers., Year: 2024\n",
      "PMID: 39112416, Title: Assessing the acceptability and appropriateness of a psychoeducational graphic novel about inherited cancer risk designed for men., Year: 2024\n",
      "PMID: 39111459, Title: Impact of molecular testing on the surgical management of advanced epithelial ovarian cancer., Year: 2024\n",
      "PMID: 39111209, Title: Adjustment for imbalances in baseline characteristics in the MAGNITUDE phase 3 study confirms the clinical benefit of niraparib in combination with abiraterone acetate plus prednisone in patients with metastatic prostate cancer., Year: 2024\n",
      "PMID: 39110344, Title: Landscape of homologous recombination deficiency in gastric cancer and clinical implications for first-line chemotherapy., Year: 2024\n",
      "PMID: 39110253, Title: Patient-derived bladder cancer organoids show stable transcript expression along cultivation., Year: 2024\n",
      "PMID: 39109923, Title: Genotype-Directed Synthetic Cytotoxicity of ATR Inhibition with Radiotherapy., Year: 2024\n",
      "PMID: 39108732, Title: Astragalus polysaccharides sensitize ovarian cancer stem cells to PARPi by inhibiting mitophagy via PINK1/Parkin signaling., Year: 2024\n",
      "PMID: 39108033, Title: Potential-Resolved Ratio Electrochemiluminescence Biosensor Based on Perylene Diimide-MOF and DNA Nanoflowers-CdS Quantum Dots for Detection of Dual Targets., Year: 2024\n",
      "PMID: 39107554, Title: BRCA1/2 Mutations and Breast/Ovarian Cancer Risk: A New Insights Review., Year: 2024\n",
      "PMID: 39107288, Title: 53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer., Year: 2024\n",
      "PMID: 39107016, Title: Using polygenic risk modification to improve breast cancer prevention: study protocol for the PRiMo multicentre randomised controlled trial., Year: 2024\n",
      "PMID: 39104720, Title: Limitations of homologous recombination status testing and poly (ADP-ribose) polymerase inhibitor treatment in the current management of ovarian cancer., Year: 2024\n",
      "PMID: 39104056, Title: Homologous recombination deficiency (HRD) is associated with better prognosis and possibly causes a non-inflamed tumour microenvironment in nasopharyngeal carcinoma., Year: 2024\n",
      "PMID: 39103848, Title: BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance., Year: 2024\n",
      "PMID: 39103402, Title: Newly synthesized chitosan nanoparticles loaded with caffeine/moringa leaf extracts Halt Her2, BRCA1, and BRCA2 expressions., Year: 2024\n",
      "PMID: 39102671, Title: Analysis of translesion polymerases in colorectal cancer cells following cetuximab treatment: A network perspective., Year: 2024\n",
      "PMID: 39102164, Title: Phenotypes of carriers of two mutated alleles in major cancer susceptibility genes., Year: 2024\n",
      "PMID: 39096911, Title: Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset., Year: 2024\n",
      "PMID: 39096699, Title: Endogenous base damage as a driver of genomic instability in homologous recombination-deficient cancers., Year: 2024\n",
      "PMID: 39096152, Title: Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene., Year: 2024\n",
      "PMID: 39095584, Title: GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathway., Year: 2024\n",
      "PMID: 39094983, Title: A duplexed high-throughput mass spectrometry assay for bifunctional POLB polymerase and lyase activity., Year: 2024\n",
      "PMID: 39091963, Title: Pure large-cell neuroendocrine carcinoma of the ovary with a somatic BRCA1 mutation: The first reported case and the review of the literature., Year: 2024\n",
      "PMID: 39091202, Title: Iron: The Secret Ingredient Breaking PARPi Resistance., Year: 2024\n",
      "PMID: 39090304, Title: XRCC2 driven homologous recombination subtypes and therapeutic targeting in lung adenocarcinoma metastasis., Year: 2024\n",
      "PMID: 39088769, Title: Germline Susceptibility to Renal Cell Carcinoma and Implications for Genetic Screening., Year: 2024\n",
      "PMID: 39085881, Title: Accuracy of renovo predictions on variants reclassified over time., Year: 2024\n",
      "PMID: 39085400, Title: Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations., Year: 2024\n",
      "PMID: 39085197, Title: BRCA1 orchestrates the response to BI-2536 and its combination with alisertib in MYC-driven small cell lung cancer., Year: 2024\n",
      "PMID: 39084178, Title: \"Bridging the DNA divide\": Understanding the interplay between replication- gaps and homologous recombination proteins RAD51 and BRCA1/2., Year: 2024\n",
      "PMID: 39084071, Title: Conditional loss of Brca1 in oocytes causes reduced litter size, ovarian reserve depletion and impaired oocyte in vitro maturation with advanced reproductive age in mice., Year: 2024\n",
      "PMID: 39083346, Title: Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancer., Year: 2024\n",
      "PMID: 39082357, Title: SMARCA2 and SMARCA4 Participate in DNA Damage Repair., Year: 2024\n",
      "PMID: 39080120, Title: Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1/2 mutation status., Year: 2024\n",
      "PMID: 39079172, Title: BAP1 loss confers sensitivity to bromodomain and extra-terminal inhibitors in renal cell carcinoma., Year: 2024\n",
      "PMID: 39078736, Title: Effectiveness of PARP inhibitor maintenance therapy in ovarian cancer by BRCA1/2 and a scar-based HRD signature in real-world practice., Year: 2024\n",
      "PMID: 39077936, Title: Multi-gene panel analysis in BRCA1/2-negative patients suspected of hereditary breast and ovarian cancer syndrome: Real-world data from a single institution., Year: 2024\n",
      "PMID: 39077473, Title: Urinary-based detection of MSL, HE4 and CA125 as an additional dimension for predictive and prognostic modelling in ovarian cancer., Year: 2024\n",
      "PMID: 39071455, Title: Low testing rates and high <i>BRCA</i> prevalence: Poly (ADP-ribose) polymerase inhibitor use in Middle East <i>BRCA</i>/homologous recombination deficiency-positive cancer patients., Year: 2024\n",
      "PMID: 39071291, Title: Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies., Year: 2024\n",
      "PMID: 39068563, Title: Type I or Type II Endometrial Carcinoma? Role of BRCA1 Immunohistochemistry., Year: 2024\n",
      "PMID: 39068216, Title: Systematic investigation of BRCA1-A, -B, and -C complexes and their functions in DNA damage response and DNA repair., Year: 2024\n",
      "PMID: 39068174, Title: Nucleolytic processing of abasic sites underlies PARP inhibitor hypersensitivity in ALC1-deficient BRCA mutant cancer cells., Year: 2024\n",
      "PMID: 39067037, Title: Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancers., Year: 2024\n",
      "PMID: 39062754, Title: Functional Characterization of the Human BRCA1 ∆11 Splicing Isoforms in Yeast., Year: 2024\n",
      "PMID: 39062738, Title: The Role of IRF9 Upregulation in Modulating Sensitivity to Olaparib and Platinum-Based Chemotherapies in Breast Cancer., Year: 2024\n",
      "PMID: 39062721, Title: <i>In Silico</i> Prediction of <i>BRCA1</i> and <i>BRCA2</i> Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients., Year: 2024\n",
      "PMID: 39061909, Title: Antioxidant Properties of Zinc and Copper-Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers., Year: 2024\n",
      "PMID: 39061239, Title: Sexual Function in Women Diagnosed with Hereditary Breast and Ovarian Cancer Syndrome., Year: 2024\n",
      "PMID: 39061202, Title: Genetic Testing Uptake among Ovarian Cancer Survivors in the Genetic Risk Analysis in Ovarian Cancer (GRACE) Study., Year: 2024\n",
      "PMID: 39061189, Title: Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients., Year: 2024\n",
      "PMID: 39061157, Title: Transcriptome-Wide Association Study Reveals New Molecular Interactions Associated with Melanoma Pathogenesis., Year: 2024\n",
      "PMID: 39060255, Title: Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers., Year: 2024\n"
     ]
    }
   ],
   "source": [
    "from Bio import Entrez\n",
    "\n",
    "def search_pubmed(gene_name):\n",
    "    # Perform a search in PubMed using Entrez esearch\n",
    "    handle = Entrez.esearch(db=\"pubmed\", term=gene_name, retmax=100)\n",
    "    record = Entrez.read(handle)\n",
    "    handle.close()\n",
    "    \n",
    "    # Get the list of PubMed IDs (PMIDs) from the search result\n",
    "    id_list = record[\"IdList\"]\n",
    "    return id_list\n",
    "\n",
    "def fetch_details(id_list):\n",
    "    ids = \",\".join(id_list)\n",
    "    handle = Entrez.efetch(db=\"pubmed\", id=ids, rettype=\"xml\", retmode=\"text\")\n",
    "    records = Entrez.read(handle)\n",
    "    handle.close()\n",
    "    return records\n",
    "\n",
    "def extract_information(records):\n",
    "    articles_info = []\n",
    "    for article in records['PubmedArticle']:\n",
    "        pmid = article['MedlineCitation']['PMID']\n",
    "        title = article['MedlineCitation']['Article']['ArticleTitle']\n",
    "        year = article['MedlineCitation']['Article']['Journal']['JournalIssue']['PubDate'].get('Year', 'Not Available')\n",
    "        articles_info.append({'PMID': pmid, 'Title': title, 'Year': year})\n",
    "    return articles_info\n",
    "\n",
    "gene_name = \"BRCA1\"  # Replace with your gene of interest\n",
    "id_list = search_pubmed(gene_name)\n",
    "records = fetch_details(id_list)\n",
    "articles_info = extract_information(records)\n",
    "\n",
    "for article in articles_info:\n",
    "    print(f\"PMID: {article['PMID']}, Title: {article['Title']}, Year: {article['Year']}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "1cee4dbf",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
